XTRA:2HRA

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts.


Snowflake Analysis

Adequate balance sheet with moderate growth potential.

Share Price & News

How has H&R GmbH KGaA's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 2HRA's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-2.0%

2HRA

4.2%

DE Chemicals

3.1%

DE Market


1 Year Return

-10.5%

2HRA

1.7%

DE Chemicals

14.0%

DE Market

Return vs Industry: 2HRA underperformed the German Chemicals industry which returned 1.7% over the past year.

Return vs Market: 2HRA underperformed the German Market which returned 14% over the past year.


Shareholder returns

2HRAIndustryMarket
7 Day-2.0%4.2%3.1%
30 Day-6.7%2.2%2.3%
90 Day44.9%21.0%18.4%
1 Year-10.5%-10.5%6.1%1.7%16.5%14.0%
3 Year-51.9%-53.6%-17.6%-26.4%7.4%-1.2%
5 Year-23.1%-25.8%-2.8%-18.7%23.8%7.2%

Price Volatility Vs. Market

How volatile is H&R GmbH KGaA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is H&R GmbH KGaA undervalued compared to its fair value and its price relative to the market?

0.62x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: 2HRA (€5.45) is trading above our estimate of fair value (€1.14)

Significantly Below Fair Value: 2HRA is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 2HRA is unprofitable, so we can't compare its PE Ratio to the DE Chemicals industry average.

PE vs Market: 2HRA is unprofitable, so we can't compare its PE Ratio to the German market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 2HRA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 2HRA is good value based on its PB Ratio (0.6x) compared to the DE Chemicals industry average (1.4x).


Next Steps

Future Growth

How is H&R GmbH KGaA forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

101.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2HRA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).

Earnings vs Market: 2HRA is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 2HRA's is expected to become profitable in the next 3 years.

Revenue vs Market: 2HRA's revenue is expected to decline over the next 3 years (-1.2% per year).

High Growth Revenue: 2HRA's revenue is forecast to decline over the next 3 years (-1.2% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 2HRA's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has H&R GmbH KGaA performed over the past 5 years?

-11.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 2HRA is currently unprofitable.

Growing Profit Margin: 2HRA is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 2HRA is unprofitable, and losses have increased over the past 5 years at a rate of 11.8% per year.

Accelerating Growth: Unable to compare 2HRA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2HRA is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-15.2%).


Return on Equity

High ROE: 2HRA has a negative Return on Equity (-2.62%), as it is currently unprofitable.


Next Steps

Financial Health

How is H&R GmbH KGaA's financial position?


Financial Position Analysis

Short Term Liabilities: 2HRA's short term assets (€313.6M) exceed its short term liabilities (€244.8M).

Long Term Liabilities: 2HRA's short term assets (€313.6M) exceed its long term liabilities (€208.6M).


Debt to Equity History and Analysis

Debt Level: 2HRA's debt to equity ratio (49.1%) is considered high.

Reducing Debt: 2HRA's debt to equity ratio has reduced from 76% to 49.1% over the past 5 years.

Debt Coverage: 2HRA's debt is well covered by operating cash flow (31.5%).

Interest Coverage: Insufficient data to determine if 2HRA's interest payments on its debt are well covered by EBIT.


Balance Sheet


Next Steps

Dividend

What is H&R GmbH KGaA current dividend yield, its reliability and sustainability?

1.43%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 2HRA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 2HRA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 2HRA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 2HRA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 2HRA is not paying a notable dividend for the German market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 2HRA's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.3yrs

Average board tenure


CEO

Niels Hansen (55 yo)

8.58yrs

Tenure

Mr. Niels H. Hansen serves as the Managing Director of Hansen & Rosenthal KG. Mr. Hansen has been Managing Director and Chairman of The Executive Board at H&R GmbH & Co. KGaA since January 01, 2012. Mr. Ha ...


CEO Compensation Analysis

Compensation vs Market: Niels's total compensation ($USD0.00) is below average for companies of similar size in the German market ($USD750.01K).

Compensation vs Earnings: Niels's compensation has increased whilst the company is unprofitable.


Board Members

NamePositionTenureCompensationOwnership
Bernd Günther
Honorary Chairman of Supervisory Board8.17yrsno datano data
Eckbert von Bohlen Und Halbach
Member of Advisory Boardno datano datano data
Reinhold Grothus
Employee Representative Member of the Supervisory Board18yrs€30.00kno data
Bernd Pfaffenbach
Member of Advisory Boardno datano datano data
Rolf Schwedhelm
Independent Member of Supervisory Board9.83yrs€45.00kno data
Wilhelm Scholten
Member of Advisory Boardno datano data5.45%
€ 11.1m
Roland Chmiel
Vice Chairman of Supervisory Board8.58yrs€65.00kno data
Holger Hoff
Employee Representative Member of the Supervisory Board3.33yrs€30.00kno data
Joachim Girg
Chairman of Supervisory Board8.25yrs€115.00kno data
Harald Januszewski
Employee Representative Member of the Supervisory Board8.25yrs€30.00kno data
Erwin Grandinger
Member of Advisory Boardno datano datano data
Sven Hansen
Member of Supervisory Board4.08yrs€50.00kno data

8.3yrs

Average Tenure

60.5yo

Average Age

Experienced Board: 2HRA's board of directors are considered experienced (8.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

H&R GmbH & Co. KGaA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: H&R GmbH & Co. KGaA
  • Ticker: 2HRA
  • Exchange: XTRA
  • Founded: 1919
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: €202.859m
  • Shares outstanding: 37.22m
  • Website: https://www.hur.com

Number of Employees


Location

  • H&R GmbH & Co. KGaA
  • Neuenkirchener Strasse 8
  • Salzbergen
  • Lower Saxony
  • 48499
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
2HRADB (Deutsche Boerse AG)YesOrdinary Bearer SharesDEEURJan 1992
2HRAXTRA (XETRA Trading Platform)YesOrdinary Bearer SharesDEEURJan 1992
0RRCLSE (London Stock Exchange)YesOrdinary Bearer SharesGBEURJan 1992
2HRADBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary Bearer SharesGBEURJan 1992

Biography

H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and P ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/14 10:27
End of Day Share Price2020/08/13 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.